(Allergan plc)

	AGN latest price $161.6900 (1.18%) ($159.4600 - $161.8600) on Wed. Sep. 4, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	3.43% (three month average)
RSI	66
Latest Price	$161.6900(1.18%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 0.6% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IVW(83%)    IWF(83%)    VT(83%)    VUG(83%)    XLC(83%)
Factors Impacting AGN price	AGN will decline at least -1.715% in a week (0% probabilities).   VXX(-71%)    VIXM(-61%)    TLT(-41%)    BWX(-11%)    IGOV(-7%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.715% (StdDev 3.43%)
Hourly BBV	0 ()
Intraday Trend	1.1%

5 Day Moving Average	$160.17(0.95%)
10 Day Moving Average	$160.3(0.87%)
20 Day Moving Average	$159.56(1.33%)
To recent high	-4.7%
To recent low	39.7%
Market Cap	$53.309b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed